On May, 31 Cantel Medical Corp. (CMD) EPS Estimated At $0.60

May 16, 2018 - By Frank Plummer

On May, 31 WallStreet expected Cantel Medical Corp. (NYSE:CMD)’s earnings report, RTT reports. Last year’s EPS was $0.51, while now analysts expect change of 17.65 % up from current $0.60 EPS. The profit will be $25.03M for CMD if $0.60 EPS becomes true. 1.69 % EPS growth is what Wall Street’s predicts after $0.59 reported EPS last quarter. Ticker’s shares touched $127.48 during the last trading session after 2.07% change.Currently Cantel Medical Corp. is uptrending after 41.41% change in last May 17, 2017. CMD has 217,886 shares volume. CMD outperformed the S&P500 by 29.86%.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide.The firm is worth $5.32 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis.59.13 is the P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

There’s an important Cantel Medical Corp. (NYSE:CMD) news posted by Benzinga.com. It’s an item titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” on May 15, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.